Featured

'Many investors still view sustainability as complementary rather than a fundamental driver of growth.'

Ardian, CapVest, Frazier Healthcare Partners and Nautics are among the PE firms investing in specialty pharmacy and pharmaceutical assets.

'Many sponsors hold large, mature portfolios and there is an increasing need to return capital as fund lives stretch. With cleaner run‑rates and more predictable trading, more assets will come to market.'

'No one knows this business better than its founder and CEO,' said One Equity's Inna Etinberg about InfuCare's Deven Patel.

'The 2025 deal environment was steady but demanding, marked by a higher bar for conviction on both sides of the table.'

'To me, if you assume moderating interest rates, an accommodating regulatory backdrop and decent GDP growth – which I think are reasonable assumptions – there will be plenty of assets coming to market,' Neary said.

The sale process represents the second time the co-investors have attempted to exit the $250m EBITDA healthcare tech company over the past two years.

Permira has appointed chief AI officers at its portfolio companies Evelyn Partners, Acuity, Westbridge and Alter Domus.

Thoma Bravo, Warburg Pincus and Turn/River Capital are among the firms involved in the biggest TMT and industrials deals of the year.

Astorg, Frazier Healthcare, Hg and Nordic Capital are among the PE firms pursuing deals around clinical data exchange assets.